Merck KGaA Statistics

Total Valuation

Merck KGaA has a market cap or net worth of EUR 49.80 billion. The enterprise value is 56.96 billion.

Market Cap	49.80B
Enterprise Value	56.96B

Important Dates

The last earnings date was Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	Apr 28, 2025

Share Statistics

Current Share Class	129.24M
Shares Outstanding	n/a
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	129.20M

Valuation Ratios

The trailing PE ratio is 17.67 and the forward PE ratio is 12.80.

PE Ratio	17.67
Forward PE	12.80
PS Ratio	2.34
PB Ratio	1.67
P/TBV Ratio	9.46
P/FCF Ratio	20.40
P/OCF Ratio	12.13
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.69, with an EV/FCF ratio of 23.33.

EV / Earnings	20.21
EV / Sales	2.67
EV / EBITDA	9.69
EV / EBIT	13.68
EV / FCF	23.33

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.29.

Current Ratio	1.31
Quick Ratio	0.69
Debt / Equity	0.29
Debt / EBITDA	1.48
Debt / FCF	3.56
Interest Coverage	17.86

Financial Efficiency

Return on equity (ROE) is 9.75% and return on invested capital (ROIC) is 6.79%.

Return on Equity (ROE)	9.75%
Return on Assets (ROA)	5.26%
Return on Invested Capital (ROIC)	6.79%
Return on Capital Employed (ROCE)	10.44%
Revenue Per Employee	340,489
Profits Per Employee	45,013
Employee Count	59,020
Asset Turnover	0.43
Inventory Turnover	1.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.70% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-29.70%
50-Day Moving Average	125.54
200-Day Moving Average	145.16
Relative Strength Index (RSI)	36.80
Average Volume (20 Days)	1,060

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Merck KGaA had revenue of EUR 21.32 billion and earned 2.82 billion in profits. Earnings per share was 6.48.

Revenue	21.32B
Gross Profit	12.66B
Operating Income	4.16B
Pretax Income	3.59B
Net Income	2.82B
EBITDA	5.88B
EBIT	4.16B
Earnings Per Share (EPS)	6.48

Full Income Statement

Balance Sheet

The company has 1.62 billion in cash and 8.70 billion in debt, giving a net cash position of -7.08 billion.

Cash & Cash Equivalents	1.62B
Total Debt	8.70B
Net Cash	-7.08B
Net Cash Per Share	n/a
Equity (Book Value)	29.90B
Book Value Per Share	68.57
Working Capital	2.91B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.11 billion and capital expenditures -1.67 billion, giving a free cash flow of 2.44 billion.

Operating Cash Flow	4.11B
Capital Expenditures	-1.67B
Free Cash Flow	2.44B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 59.39%, with operating and profit margins of 19.53% and 13.22%.

Gross Margin	59.39%
Operating Margin	19.53%
Pretax Margin	16.86%
Profit Margin	13.22%
EBITDA Margin	27.57%
EBIT Margin	19.53%
FCF Margin	11.45%

Dividends & Yields

This stock pays an annual dividend of 2.20, which amounts to a dividend yield of 1.89%.

Dividend Per Share	2.20
Dividend Yield	1.89%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	36.37%
Buyback Yield	-0.14%
Shareholder Yield	1.75%
Earnings Yield	5.66%
FCF Yield	4.90%

Dividend Details

Stock Splits

The last stock split was on June 30, 2014. It was a forward split with a ratio of 2.

Last Split Date	Jun 30, 2014
Split Type	Forward
Split Ratio	2

Scores

Merck KGaA has an Altman Z-Score of 3.48.

Altman Z-Score	3.48
Piotroski F-Score	n/a